封面
市場調查報告書
商品編碼
1532412

細胞冷凍保存市場:按產品類型、按應用、按最終用戶、按地區

Cell Cryopreservation Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 192 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2024年全球細胞冷凍保存市場規模將達101億美元,預計2031年將達431.1億美元,2024年至2031年複合年成長率為23%。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 101億美元
實際資料 2019-2023 預測期 2024年至2031年
預測 2024-2031 年複合年成長率: 23.00% 2031年價值預測 431.1億美元
圖. 2024年各地區細胞冷凍保存市場佔有率(%)
細胞冷凍保存市場-IMG1

細胞冷凍保存使用液態氮在極低的溫度(通常低於-80°C)下冷卻並保存細胞。細胞可以保存很久而不影響細胞活力。癌症和遺傳疾病的增加、再生醫學研究、幹細胞庫、生育治療和組織工程投資的增加等因素可能會推動研究機構和醫院對細胞冷凍保存過程的需求。冷凍保存設備和解決方案的技術進步也將支持市場成長。然而,與冷凍保存程序和設備相關的高成本可能會阻礙預測期內的市場成長。

市場動態:

全球細胞冷凍保存市場成長的主要驅動力是慢性和危及生命的疾病盛行率的上升。癌症和遺傳疾病的全球流行正在推動對嚴重依賴冷凍細胞的研究活動、細胞療法和臨床試驗的需求。根據世界癌症研究基金會的數據,2020 年全球將報告約 1,800 萬新癌症病例。此外,公共和私人對再生醫學、幹細胞研究和醫學生物技術創新的投資增加也支持了冷凍保存流程的採用。然而,與冷凍保存設備、液態氮和整體程序相關的高成本可能會阻礙市場成長。此外,缺乏熟練的專業人員以及耗時的冷凍過程中的技術挑戰也可能阻礙市場成長。機器人冷凍保存技術和設備的持續市場開拓可能會提供利潤豐厚的市場成長機會。

本研究的主要特點

  • 本報告詳細分析了全球細胞冷凍保存市場,並提供了以2023年為基準年的預測期(2024-2031)的市場規模和年複合成長率(CAGR%)。
  • 它揭示了各個細分市場的潛在商機,並解釋了該市場中有吸引力的投資提案的矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數,介紹了全球細胞冷凍保存市場的主要企業。
  • 該報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球細胞冷凍保存市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球細胞冷凍保存市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管場景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第4章全球細胞冷凍保存市場 - 冠狀病毒(COVID-19)大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第5章全球細胞冷凍保存市場,依產品類型,2019-2031

  • 防凍劑
  • 甘油
  • 二甲基亞碸(DMSO)
  • 其他
  • 裝置
  • 培養箱
  • 液態氮供應罐
  • 冷凍庫
  • 其他

第6章全球細胞冷凍保存市場,依應用分類,2019-2031

  • 幹細胞
  • 卵子和胚胎細胞
  • 精子細胞
  • 肝細胞
  • 其他

第 7 章 全球細胞冷凍保存市場,依最終使用者分類,2019-2031 年

  • 生物製藥和製藥公司
  • 研究所
  • 生物樣本庫
  • 試管嬰兒診所
  • 其他

第8章全球細胞冷凍保存市場,按地區,2019-2031,(十億美元)

  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東

第9章 競爭格局

  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GE Healthcare
    • Lonza Group Ltd.
    • STEMCELL Technologies Inc.
    • BioLife Solutions, Inc.
    • Cryolife, Inc.
    • Organ Recovery Systems Inc.
    • Custom Biogenic Systems
    • Sartorius AG
    • Takara Bio Inc.
    • Chart Industries, Inc.
    • Biocision, LLC
    • Cardinal Health, Inc.
    • Helmer Scientific

第10章分析師建議

  • 命運之輪
  • 分析師觀點
  • 一致的機會圖

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1698

Global cell cryopreservation market is estimated to be valued at USD 10.10 Bn in 2024 and is expected to reach USD 43.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 23% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 10.10 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 23.00% 2031 Value Projection: US$ 43.11 Bn
Figure. Cell Cryopreservation Market Share (%), By Region 2024
Cell Cryopreservation Market - IMG1

Cell cryopreservation involves preserving cells by cooling them to extremely low temperatures, usually -80°C or below using liquid nitrogen. It helps to preserve cells for a very long period of time without affecting their viability. Factors such as rising prevalence of cancers and genetic disorders, increasing investments in regenerative medicine research, stem cell banking, fertility preservation and tissue engineering can boost demand for cell cryopreservation processes across research institutes and hospitals. Technological advancements in cryopreservation equipment and solutions can also drive the market growth. However, high costs associated with cryopreservation procedures and equipment can hamper the market growth during the forecast period.

Market Dynamics:

Global cell cryopreservation market growth is mainly driven by rising incidence of chronic and life-threatening diseases. Growing prevalence of cancers and genetic disorders globally boosts demand for research activities, cell therapies and clinical trials which heavily rely on cryopreserved cells. According to the World Cancer Research Fund, approximately 18 million new cancer cases were reported globally in 2020. Furthermore, increasing investments by both public and private players in regenerative medicine, stem cell research and medical biotech innovations have also boosted the uptake of cryopreservation processes. However, high costs associated with cryopreservation equipment, liquid nitrogen and overall procedures can hamper the market growth. Lack of skilled professionals and technical challenges during slow freezing processes can also hamper the market growth. Ongoing developments in robotic cryostorage technologies and equipment can offer lucrative market growth opportunities.

Key Features of the Study:

  • This report provides in-depth analysis of the global cell cryopreservation market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cell cryopreservation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Nippon Genetics, Miltenyi Biotec, Mediatech, Inc., Genzyme Corporation, BioLifeSolutions, Inc., VWR International, LLC, and BiolifeSolutions, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market

Detailed Segmentation-

  • By Product Type
    • Cryoprotectant Agents
    • Glycerol
    • Dimethyl Sulfoxide (DMSO)
    • Others
    • Equipment
    • Incubators
    • Liquid Nitrogen Supply Tanks
    • Freezers
    • Others
  • By Application
    • Stem Cells
    • Oocytes and Embryotic cells
    • Sperm Cells
    • Hepatocytes
    • Others
  • By End User
    • Biopharmaceutical & Pharmaceutical Companies
    • Research Institutes
    • Biobanks
    • IVF clinics
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GE Healthcare
    • Lonza Group Ltd.
    • STEMCELL Technologies Inc.
    • BioLife Solutions, Inc.
    • Cryolife, Inc.
    • Organ Recovery Systems Inc.
    • Custom Biogenic Systems
    • Sartorius AG
    • Takara Bio Inc.
    • Chart Industries, Inc.
    • Biocision, LLC
    • Cardinal Health, Inc.
    • Helmer Scientific

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Cell Cryopreservation Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Cell Cryopreservation Market, By Product Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Cryoprotectant Agents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Glycerol
  • Dimethyl Sulfoxide (DMSO)
  • Others
  • Equipment
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Incubators
  • Liquid Nitrogen Supply Tanks
  • Freezers
  • Others

6. Global Cell Cryopreservation Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Stem Cells
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Oocytes and Embryotic cells
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Sperm Cells
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Hepatocytes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Cell Cryopreservation Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Biopharmaceutical & Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Biobanks
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • IVF clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Cell Cryopreservation Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck KGaA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GE Healthcare
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Lonza Group Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • STEMCELL Technologies Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BioLife Solutions, Inc.
    • Cryolife, Inc.
    • Organ Recovery Systems Inc.
    • Custom Biogenic Systems
    • Sartorius AG
    • Takara Bio Inc.
    • Chart Industries, Inc.
    • Biocision, LLC
    • Cardinal Health, Inc.
    • Helmer Scientific

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact